MedTrace Logo

Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis

NCT01160081 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3658

Last updated 2011-01-25

No results posted yet for this study

Summary

The purpose of this study is to determine the seroprevalence of Hepatitis A Virus (HAV), Varicella-Zoster virus (VZV), Cytomegalovirus (CMV), Herpes Simplex (HSV) and Bordetella pertussis (BP)infections in Mexico.

Conditions

  • Viral Hepatitis Vaccines
  • Hepatitis A
  • Cytomegalovirus
  • Varicella-Zoster Virus
  • Bordetella Pertussis Infection
  • Herpes Simplex (1 and 2)

Interventions

OTHER

Serum sample

Serum samples collected

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
1 Year
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01160081 on ClinicalTrials.gov